-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
September 01, 2022 - treatment and comparator groups
were imbalanced in terms of factors that were common causes of both the choice
-
integrationacademy.ahrq.gov/sites/default/files/2025-06/Innovations%20in%20Behavioral%20Health%20Integration_Transcript.docx
January 01, 2025 - Stephens: equivalent or appropriate on that level, and then someone of their choice that they thought
-
hcup-us.ahrq.gov/db/nation/nis/NISIntroduction2019.pdf
September 01, 2021 - The choice of an appropriate method
for calculating variances for nationwide estimates depends on the
-
www.ahrq.gov/sites/default/files/publications2/files/MeasureDx-guide.pdf
July 01, 2022 - The choice of measurement strategy depends on your diagnostic safety team’s goals, expertise, technical
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cerebral-palsy-feeding_executive.pdf
March 01, 2013 - 1
Comparative Effectiveness Review
Number 94
Interventions for Feeding and Nutrition
in Cerebral Palsy
Executive Summary
Background
Cerebral palsy (CP) is a “group of
disorders of the development of
movement and posture, causing
activity limitation, that is attributed to
non-progressive disturbances that…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_executive.pdf
April 01, 2012 - 1
Comparative Effectiveness Review
Number 60
Treatment for Glaucoma:
Comparative Effectiveness
Executive Summary
Background
Glaucoma is a leading cause of visual
impairment and blindness both in the
United States and worldwide. It is
estimated to affect 60.5 million people
worldwide.1 Glaucoma is defined as…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
November 01, 2012 - 1
Comparative Effectiveness Review
Number 86
Treatment for Restless Legs Syndrome
Executive Summary
Introduction
Restless legs syndrome (RLS) is a
neurological disorder characterized
by unpleasant sensations in the legs
and a distressing, irresistible urge to
move them. RLS can result in reduced
quality o…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_executive.pdf
September 01, 2011 - Layout 1
Background
Antipsychotics medications are approved
by the U.S. Food and Drug Administration
(FDA) for treatment of schizophrenia and
bipolar disorder. These medications are
commonly divided into two classes,
reflecting two waves of historical
development: the conventional
antipsychotics and the atypical. T…
-
digital.ahrq.gov/sites/default/files/docs/page/D_ITPrivacyandSecurityPrimer_1.pdf
March 20, 1997 - D_ITPrivacyandSecurityPrimer
Appendix D:
IT Privacy and Security Primer
PART 1:
GENERAL PRIVACY CONSIDERATIONS1
Introduction
The purpose of this IT Privacy and Security Primer is to provide a broad overview of what
privacy in health care represents. This section is not intended to address the state a…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/venous-ulcers-treatment_executive.pdf
January 01, 2014 - 1
Comparative Effectiveness Review
Number 127
Chronic Venous Ulcers: A Comparative
Effectiveness Review of Treatment Modalities
Executive Summary
Background
Venous leg ulcers are extremely common
in the United States. They affect between
500,000 and 2 million people annually, and
are responsible for over 50 pe…
-
www.ahrq.gov/sites/default/files/publications/files/clabsicompanion.pdf
October 18, 2012 - Eliminating CLABSI, A National Patient Safety Imperative: Final Report Companion Guide
Eliminating CLABSI,
A National Patient Safety
Imperative
A Companion Guide to the National On the CUSP: Stop BSI
Project Final Report
A Project of:
Health Research & Educational Trust
Johns Hopkins Medicine A…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0123-fullreport.pdf
November 01, 2019 - High-Risk Deliveries at Facilities with Level 3 or Higher NICU Services on Campus
1
High-Risk Deliveries at Facilities with Level 3 or
Higher NICU Services on Campus
Section 1. Basic Measure Information
1.A. Measure Name
High-Risk Deliveries at Facilities with Level 3 or Higher NICU Services on Campus
1.B. Me…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0122-fullreport.pdf
September 01, 2019 - High-Risk Deliveries at Facilities with 24/7 In-House Blood Banking/Transfusion Services - Report
High-Risk Deliveries at Facilities with 24/7 In-House
Blood Banking/Transfusion Services Available
Section 1. Basic Measure Information
1.A. Measure Name
High-Risk Deliveries at Facilities with 24/7 In-House Blood B…
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/NCINQTobaccoUseHelpForm.pdf
August 01, 2012 - NCINQ Measure Submission: Tobacco Use and Help with Quitting Among Adolescents
Attachment A: CHIPRA Pediatric Quality Measures Program (PQMP) Candidate
Measure Submission Form (CPCF)
Italics indicate instructions for how to complete a specific field. << >> indicates the name of a text field in the
online version o…
-
digital.ahrq.gov/sites/default/files/docs/page/D_ITPrivacyandSecurityPrimer_0.pdf
March 20, 1997 - D_ITPrivacyandSecurityPrimer
Appendix D:
IT Privacy and Security Primer
Privacy and Security Assessment of Variation Toolkit D-1
PART 1:
GENERAL PRIVACY CONSIDERATIONS1
Introduction
The purpose of this IT Privacy and Security Primer is to provide a broad overview of what
privacy in health …
-
meps.ahrq.gov/data_files/publications/mr12/mr12.pdf
June 01, 2001 - Methodology Report #12: Outpatient Prescription Drugs: Data Collection and Editing in the 1996 Medical Expenditure Survey (HC-010A)
�����
�����
yyyyy
yyyyyReport 12
Outpatient Prescription Drugs:
Data Collection and Editing in the
1996 Medical Expenditure Panel
Survey (HC-010A)
Methodology Methodology
U.S. De…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer-update_executive.pdf
December 01, 2014 - 1
Radiotherapy Treatments for Head and Neck
Cancer Update
Executive Summary
Introduction
Objectives
In May 2010, the Agency for Healthcare
Research and Quality (AHRQ) published
the results of Comparative Effectiveness
Review (CER) No. 20, “Comparative
Effectiveness and Safety of Radiotherapy
Treatments for H…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/hDZUZdx4qLNc2PjbkfWQuw
April 01, 2016 - Collaborative Modeling of the Benefits and Harms Associated With
Different U.S. Breast Cancer Screening Strategies
Jeanne S. Mandelblatt, MD, MPH; Natasha K. Stout, PhD; Clyde B. Schechter, MA, MD; Jeroen J. van den Broek, MS;
Diana L. Miglioretti, PhD; Martin Krapcho, BS; Amy Trentham-Dietz, PhD, MS; Diego Munoz, PhD,…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-provider-adherence_executive.pdf
May 01, 2013 - 1
Comparative Effectiveness Review
Number 95
Interventions To Modify Health Care Provider
Adherence to Asthma Guidelines
Executive Summary
Background
Asthma is a respiratory disease
characterized by variable and recurring
symptoms, airflow obstruction,
bronchial hyper-responsiveness, and
inflammation of the…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cesarean-birth-2010_disposition-comments.pdf
January 01, 2010 - While the Cochrane Risk of Bias tool is certainly a reasonable
choice, the issue of blinding in behavioral